Image de couverture de livre

Efficacy and Safety of Twelve Anti‐Dyskinetic Drugs in Parkinson's Disease: A Bayesian Network Meta‐Analysis of Randomized Controlled Trials

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fei‐Fei Chen, Si‐Yuan Wen, Xiang‐Ting Chen, Qian Zhang, Pan Tao, Chi Meng, Jing Huang, Wei Chen, Chang‐Qing Zhou
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	European Journal of Neurology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Time to Change the Drug Trial Paradigm for Dravet Syndrome: Designing Trials for the Disease Rather than Squeezing the Disease into the Trial
par: Ingrid E. Scheffer, et autres
Publié: (2025)

Reconsidering Central and Peripheral Contributions to Propranolol's Anti Tremor Effects in Parkinson's Disease
par: Sijia Zhu, et autres
Publié: (2025)

A Randomized, Double‐Blind Clinical Trial to Evaluate the Non‐Inferiority of the Efficacy and Safety of Dyston to Dysport for Preventive Treatment of Chronic Migraine
par: Elham Jafari, et autres
Publié: (2025)

Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta‐Analysis
par: Matthew Burton, et autres
Publié: (2026)

Minimally Invasive Surgery for Spontaneous Intracerebral Hemorrhage: Meta‐Analysis of High‐Quality Randomized Clinical Trials
par: Ahmed Alkhiri, et autres
Publié: (2024)

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative
par: Daniel Weintraub, et autres
Publié: (2026)

Anti‐ IgLON5 Disease: A Systematic Review and Meta‐Analysis
par: Anna Grossauer, et autres
Publié: (2025)

Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study
par: Kundian Guo, et autres
Publié: (2025)

Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
par: María E. Jimenez-Capdeville, et autres
Publié: (2025)

Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease
par: Shannon Y. Chiu, et autres
Publié: (2026)

Efficacy and Safety of Endovascular Thrombectomy in Large‐Core Infarcts: A Systematic Review and Meta‐Analysis
par: Abhishek Dixit, et autres
Publié: (2025)

Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control Trials
par: Khaled Gharaibeh, et autres
Publié: (2024)

Assessing Real World Efficacy, Safety, and 18‐Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies
par: Nicole Chemaly, et autres
Publié: (2025)

Pleiotropy and the Increasing Complexity of Parkinson's Disease Genetics
par: Jonggeol Kim, et autres
Publié: (2025)

Combined Vascular Parkinsonism and Parkinson’s Disease: A Case Report
par: Mitsunori Morimatsu, et autres
Publié: (2026)

Predictive Value of Perivascular Space Network and Choroid Plexus for Levodopa Responsiveness in Parkinson's Disease
par: Zekai Chen, et autres
Publié: (2025)

Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
par: Paulina Gonzalez‐Latapi, et autres
Publié: (2026)

The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta‐Analysis
par: Christoph Theyer, et autres
Publié: (2025)

Real‐World Use of Cenobamate in Paediatric Drug‐Resistant Epilepsy: Long‐Term Efficacy, Safety, and Co‐Medication Adjustment
par: Tiziana Pisano, et autres
Publié: (2026)

Sternocleidomastoid Muscle Overactivity: A Potentially Critical Contributor to Postural Abnormalities in Parkinson's Disease
par: Sha Zhu, et autres
Publié: (2025)

Screening and Clinical Validation of Ferroptosis‐Related Genes in Acute Ischemic Stroke
par: Li Chen, et autres
Publié: (2025)

Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
par: Verena Dzialas, et autres
Publié: (2025)

Heart Rate Profiles During Exercise and Incident Parkinson's Disease
par: Stefan van Duijvenboden, et autres
Publié: (2025)

Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease
par: Capucine Piat, et autres
Publié: (2025)

Efficacy of Intermittent Theta‐Burst Stimulation for Prolonged Disorders of Consciousness: A Prospective, Randomized, Controlled Trial
par: Chuan Xu, et autres
Publié: (2026)

Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk
par: Amei Chen, et autres
Publié: (2025)

Combination Disease‐Modifying Therapy for Neurodegenerative Diseases Using Repurposed Drugs
par: Alexander Shtilbans, et autres
Publié: (2026)

The Clinical Effect of Annonaceae Fruit Consumption on Caribbean Parkinson′s Disease Severity
par: Louis Ribeyron, et autres
Publié: (2026)

Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease
par: Deepika Dinesh, et autres
Publié: (2026)

Reply to “An Apple a Day Will Not Keep the (Parkinson's Disease) Doctor at Bay!”
par: Erik Post, et autres
Publié: (2024)

Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems
par: Alex I. Wiesman, et autres
Publié: (2024)

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker‐Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
par: Ethan G. Brown, et autres
Publié: (2026)

Prioritizing Modifiable Risk Factors for Dementia Prevention across the Spectrum of Genetic Susceptibility: A Prospective Cohort Study
par: Fei Tian, et autres
Publié: (2025)

Global, Regional, and National Burden of Stroke on Children and Adolescents Aged Under 20 Years From 1990 to 2021, With Projections of Disability‐Adjusted Life Year to 2050: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021
par: Jing‐Jie Li, et autres
Publié: (2025)

Dementia Incidence in Individuals With Parkinson's Disease in the Framingham Heart Study
par: Joshi Dookhy, et autres
Publié: (2026)

Elucidating Pathological Mechanisms and Developing Biomarkers of Parkinson's Disease
par: Taku Hatano
Publié: (2025)

Olfactory Dysfunction as a Window Into the Heterogeneity of Parkinson Disease
par: Yeeun Sun, et autres
Publié: (2025)

Olfactory Dysfunction and/or RBD for Mapping Parkinson's Disease Subtypes?
par: Vittorio Velucci, et autres
Publié: (2025)

Immediate Motor Control Enhancement via Pallidothalamic Tract (PTT) Circuit Ablation: A Dual‐Target MR‐Guided Focused Ultrasound Approach for Tremor‐Dominant Parkinson's Disease
par: Jui‐Cheng Chen, et autres
Publié: (2025)

Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease
par: Yue Jing Heng, et autres
Publié: (2026)